Clinical Trials

NCT06741072 | RECRUITING | PHASE1
55 participants

BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-02
Start Date:
2026-06-28
Completion:
2027-07-31
Conditions
  • Chronic Kidney Disease, Stage 4
  • Chronic Kidney Disease, Stage 5
  • EBV-Related Lymphoproliferative Disorder
  • EBV-Related Malignant Neoplasm
  • Post-Transplant Lymphoproliferative Disorder
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT06738368 | RECRUITING | PHASE2
30 participants

Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-02
Start Date:
2026-05-08
Completion:
2028-01-31
Conditions
  • B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
  • T Acute Lymphoblastic Leukemia
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT06564519 | COMPLETED | NA
12 participants

Resident Posture Biofeedback Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-02
Start Date:
2024-09-26
Completion:
2025-11-02
Conditions
  • Postural; Strain
  • Healthy
Interventions
  • DEVICE
No Results Yet
NCT06459635 | RECRUITING
70 participants

Migraine Attack Pain Phase Prediction Study

Study Type:
OBSERVATIONAL
Last Updated:
2026-07-02
Start Date:
2023-10-09
Completion:
2026-07-31
Conditions
  • Migraine
  • Migraine Headache
  • Migraine Disorders
  • Migraine Without Aura
  • Migraine With Aura
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page